IDW2BB
Established Member
- Reaction score
- 19
Thanks for the lymphatic study info, I will go through these over the weekend. At first glance they seem to fit with my thinking on the immunology effect, that I consider very important in female susceptibility to autoimmune disease.
I think with a topical, it would be more effective to use a 5ARI type 2 inhibitor in this application. Any androgen blocker would according to this mechanism, need to reach the deeper lymphatic's of the face and neck. I think a topical would have a problem here. Reducing the amount of DHT produced in the surface structures by a topical would be easier I think, and a type 2 inhibitor alone should be enough as this produces two thirds of local DHT.
We just need to target the large follicles of the scalp and beard area.
Yes I think the principle is the same in Macaques, also related to the action of androgens. Remember the principles of this growth adjustment mechanism, are natural tissue resistance modified by changing local fluid pressures. This explains the differences In patterns and susceptibility in primates , and modern human hairlessness as I argue in my paper.
- - - Updated - - -
Yes I do think the Galea does have an effect for the following reason.
Any increase in local tissue fluid pressure, has a natural dispersal to surrounding lower pressure areas This is the basic physics of pressure differences. The Galea is a membrane that hinders this equalisation of pressure from the male pattern baldness area. I see it as another factor that is not causal, but adds to the retention of excess fluid in male pattern baldness.
Armando, you say eyelash hair is different, in what way? In this mechanism, what is important is not the make up of the hair fibre, but the follicle structure. If its a pocket and the production area protrudes into its base, the physics of this mechanism still apply.
Talking about lymphatic layouts, I would love to see the surface lymphatic layout of lions. I am willing to bet this tells a story about the androgen induced male lions mane.
I will read the posted studies, and post again over the weekend.
Look forward to your input. Might want to check this out as well:
http://www.google.com/patents/EP2153836A1?cl=en
It is a patent on a topical Finasteride formulation that seems to reduce systemic effects while also inhibiting 5ar type 1 to a greater extent than the oral form of finasteride.
What is crazy about the potential of this topical if the research bears out, is that it should be perfect for what you suggest. Using it on the "donor" area and the face.